The molecular basis of MHC class II deficiency and transcriptional control of MHC class II gene expression

Microbes and Infection

Volumn 1, Issue 11, 1999, Pages 839-846

  Reith, Walter ^a   Muhlethaler Mottet, Annick ^a   Masternak, Krzysztof ^a   Villard, Jean ^a   MacH, Bernard ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

BINDING SITE; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; REVIEW; TRANSCRIPTION REGULATION;

EID: 0032719308     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(99)00235-X     Document Type: Article

References (45)

1. Bannister A.J., Kouzarides T. The CBP coactivator is a histone acetyltransferase. Nature. 384:1996;641-643.
2. Benichou B., Strominger J.L. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA. 88:1991;4285-4288.
3. Bottazzo G.F., Todd I., Mirakian R., Belfiore A. Pujol-Borrell R, Organ-specific autoimmunity: a (1986) overview. Immunol. Rev. 94:1986;137-169.
4. Chang C.H., Guerder S., Hong S.C., Van Ewijk W., Flavell R.A. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 4:1996;167-178.
5. Chin K.C., Li G.G., Ting J.P. Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants. Proc. Natl. Acad. Sci. USA. 94:1997;2501-2506.
6. Clausen B., Waldburger J., Schwenk F., Barras E., Mach B., Rajewski K., Förster I., Reith W. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity. 8:1998;143-155.
7. De Preval C., Lisowska-Grospierre B., Loche M., Griscelli C., Mach B. A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes. Nature. 318:1985;291-293.
8. Durand B., Kobr M., Reith W., Mach B. Functional complementation of MHC class II regulatory mutants by the purified X box binding protein RFX. Mol. Cell Biol. 14:1994;6839-6847.
9. Durand B., Sperisen P., Emery P., Barras E., Zufferey M., Mach B., Reith W. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16:1997;1045-1055.
10. Fondaneche M.C., Villard J., Wiszniewski W., Jouanguy E., Etzioni A., Le Deist F., Peijnenburg A., Casanova J.L., Reith W., Mach B., Fischer A., Lisowska-Grospierre B. Genetic and molecular definition of complementation group D in MHC class II deficiency. Hum. Mol. Genet. 7:1998;879-885.
11. Fontes J.D., Jiang B., Peterlin B.M. The class II trans- activator CIITA interacts with the TBP-associated factor TAF II 32. Nucleic Acids Res. 25:1997;2522-2528.
12. Fontes J.D., Kanazawa S., Jean D., Peterlin B.M. Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes. Mol. Cell Biol. 19:1999;941-947.
13. Gobin S.J., Peijnenburg A., Van Eggermond M., Van Zutphen M., Van Den Berg R., Van Den Elsen P.J. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes. Immunity. 9:1998;531-541.
14. Hobart M., Ramassar V., Goes N., Urmson J., Halloran P.F. IFN- regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo. J. Immunol. 158:1997;4260-4269.
15. Kara C.J., Glimcher L.H. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science. 252:1991;709-712.
16. Kara C.J., Glimcher L.H. Developmental and cytokine-mediated regulation of MHC class II gene promoter occupancy in vivo. J. Immunol. 150:1993;4934-4942.
17. Klein C., Lisowska Grospierre B., Ledeist F., Fischer A., Griscelli C. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J. Pediatr. 123:1993;921-928.
18. Kretsovali A., Agalioti T., Spilianakis C., Tzortzakaki E., Merika M., Papamatheakis J. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol. Cell Biol. 18:1998;6777-6783.
19. Lee Y.J., Benveniste E.N. Stat1 alpha expression is involved in IFN-gamma induction of the class II transactivator and class II MHC genes. J. Immunol. 157:1996;1559-1568.
20. Lennon A.M., Ottone C., Rigaud G., Deaven L.L., Longmire J., Fellous M., Bono R., Alcaide-Loridan C. Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics. 45:1997;266-273.
21. Louis-Plence P., Moreno C., Boss J. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. J. Immunol. 159:1997;3899-3909.
22. Lu H.T., Riley J.L., Babcock G.T., Huston M., Stark G.R., Boss J.M., Ransohoff R.M. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma. J. Exp. M. 182:1995;1517-1525.
23. Mach B., Steimle V., Martinez-Soria E., Reith W. Regulation of MHC class II genes: Lessons from a disease. Annu. Rev. Immunol. 14:1996;301-331.
24. Masternak K., Barras E., Zufferey M., Conrad B., Corthals G., Aebersold R., Sanchez J.C., Hochstrasser D.F., Mach B., Reith W. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20:1998;273-277.
25. Moreno C.S., Rogers E.M., Brown J.A., Boss J.M. Regulatory factor X, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex. J. Immunol. 158:1997;5841-5848.
26. Muhlethaler-Mottet A., Otten L.A., Steimle V., Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:1997;2851-2860.
27. Muhlethaler-Mottet A., Di Berardino W., Otten L.A., Mach B. Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity. 8:1998;157-166.
28. Nandan D., Reiner N.E. TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action. J. Immunol. 158:1997;1095-1101.
29. Otten L.A., Steimle V., Bontron S., Mach B. Quantitative control of MHC class II expression by the transactivator CIITA. Eur. J. Immunol. 28:1998;473-478.
30. Piskurich J.F., Wang Y., Linhoff M.W., White L.C., Ting J.P. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene. J. Immunol. 160:1998;233-240.
31. Piskurich J.F., Linhoff M.W., Wang Y., Ting J.P.Y. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta. Mol. Cell Biol. 19:1999;431-440.
32. Reith W., Kobr M., Emery P., Durand B., Siegrist C.A., Mach B. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J. Biol. Chem. 269:1994;20020-20025.
33. Reith W., Siegrist C.A., Durand B., Barras E., Mach B. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA. 91:1994;554-558.
34. Riley J.L., Westerheide S.D., Price J.A., Brown J.A., Boss J.M. Activation of class II MHC genes requires both the X box and the class II transactivator (CIITA). Immunity. 2:1995;533-543.
35. Scholl T., Mahanta S.K., Strominger J.L. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA. 94:1997;6330-6334.
36. Seidl C., Saraiya C., Osterweil Z., Fu Y.P., Lee J.S. Genetic complexity of regulatory mutants defective for HLA class-II gene-expression. J. Immunol. 148:1992;1576-1584.
37. Silacci P., Mottet A., Steimle V., Reith W., Mach B. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. M. 180:1994;1329-1336.
38. Steimle V., Otten L.A., Zufferey M., Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 75:1993;135-146.
39. Steimle V., Siegrist C., Mottet A., Lisowska-Grospierre B., Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science. 265:1994;106-109.
40. Steimle V., Durand B., Barras E., Zufferey M., Hadam M.R., Mach B., Reith W. A novel DNA binding regulatory factor is mutated in primary MHC class II deficiency (Bare Lymphocyte Syndrome). Genes Dev. 9:1995;1021-1032.
41. Vilen B.J., Cogswell J.P., Ting J.P. Stereospecific alignment of the X and Y elements is required for major histocompatibility complex class II DRA promoter function. Mol. Cell. Biol. 11:1991;2406-2415.
42. Villard J., Lisowska-Grospierre B., Van Den Elsen P., Fischer A., Reith A., Mach B. Primary MHC class II deficiency: genetic and molecular definition of a novel complementation group. N. Engl. J. M. 337:1997;748-753.
43. Villard J., Muhlethaler-Mottet A., Bontron S., Mach B., Reith W. CIITA-induced occupation of MHC class II promoters is independant of the cooperative stabilization of the promoter-bound multi-protein complexes. Int. Immunol. 11:1999;461-469.
44. Wright K., Chin K., Linhoff M., Skinner C., Brown J., Boss J., Stark G., Ting J. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo. Proc. Natl. Acad. Sci. USA. 95:1998;6267-6272.
45. Zhou H., Glimcher L.H. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity. 2:1995;545-553.